Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Brainsway Ltd BWAY

Alternate Symbol(s):  BRSYF

Healthcare Medical Devices
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders... see more

Recent & Breaking News (NDAQ:BWAY)

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS(TM) Treatment December 1, 2025

GlobeNewswire 13 days ago

BrainsWay Launches First Clinical Trial of Deep TMS 360(TM) System for Alcohol Use Disorder

GlobeNewswire November 17, 2025

BrainsWay Receives FDA Clearance of Deep TMS(TM) as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

GlobeNewswire November 13, 2025

BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights

GlobeNewswire November 11, 2025

BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder

GlobeNewswire November 4, 2025

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

GlobeNewswire October 28, 2025

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers

GlobeNewswire October 27, 2025

BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)

GlobeNewswire September 16, 2025

Neurolief Prepares for Launch of its Proliv(TM)Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay

PR Newswire August 21, 2025

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

GlobeNewswire August 21, 2025

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

GlobeNewswire August 20, 2025

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

GlobeNewswire August 13, 2025

BrainsWay Champions TMS Education with Sponsorship of Two Free CME Courses for Mental Health Professionals

GlobeNewswire July 30, 2025

BrainsWay to Report Second Quarter 2025 Financial Results on August 13, 2025

GlobeNewswire July 30, 2025

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

GlobeNewswire June 11, 2025

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

GlobeNewswire June 10, 2025

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

GlobeNewswire June 4, 2025

BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights

GlobeNewswire May 13, 2025

BrainsWay to Showcase Deep TMS at the 2025 American Psychiatric Association Annual Meeting in Los Angeles

GlobeNewswire May 1, 2025

BrainsWay to Report First Quarter 2025 Financial Results on May 13, 2025

GlobeNewswire April 29, 2025